ArtifactPublicationStatus: Active

url: Citation Citation for EBMonFHIR Implementation Guide

identifier: FEvIR Object Identifier/385938, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.15.59

version: 1.0.0-ballot2

title: Citation for EBMonFHIR Implementation Guide

status: Active

date: 2025-09-04 23:28:30+0000

author: Brian S. Alper, MD, MSPH:

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description:

jurisdiction: World

copyright:

summary

style: Computable Publishing

text:

Evidence Based Medicine on FHIR Implementation Guide [Database Entry]. Contributors: HL7 International [Publisher]. Identifier {from urn:ietf:rfc:3986} OID:2.16.840.1.113883.4.642.40.44. Published March 28, 2025. Accessed July 22, 2025. Available at: http://hl7.org/fhir/uv/ebm/2025May/.

summary

style: NLM

text:

Evidence Based Medicine on FHIR Implementation Guide [Internet]. Version 1.0.0-ballot2. Ann Arbor (MI): HL7 International. 2025 Mar 28. Available from: http://hl7.org/fhir/uv/ebm/2025May/.

citedArtifact

identifier: Uniform Resource Identifier (URI)/OID:2.16.840.1.113883.4.642.40.44

dateAccessed: 2025-07-22

title

type: Primary title

text:

Evidence Based Medicine on FHIR Implementation Guide

title

type: Acronym

text:

EBMonFHIR IG

title

type: Short title

text:

EBMonFHIR Implementation Guide

title

type: Machine use

text:

EBMIG

Abstracts

-	Type	Text	Copyright
*	Primary human use	The FHIR Resources for Evidence Based Medicine Knowledge Assets ('EBMonFHIR') Implementation Guide defines profiles and value sets for the representation of scientific knowledge. This implementation guide is intended for developers of systems using FHIR for data exchange of scientific knowledge and for authors of more specialized implementation guides in this domain. This implementation guide covers the broad scope of representation of scientific knowledge, including (1) citations to represent identification, location, classification, and attribution for knowledge artifacts; (2) components of research study design including study eligibility criteria (cohort definitions) and endpoint analysis plans; (3) research results including the statistic findings, definition of variables for which those findings apply, and the certainty of these findings; (4) assessments of research results; (5) aggregation and synthesis of research results; (6) judgments regarding evidence syntheses and contextual factors related to recommendations; (7) recommendations; and (8) compositions of combinations of these types of knowledge. The types of interoperability covered include syntactic (Resource StructureDefinitions) and semantic (value sets).	© 2024+ HL7 International / Clinical Decision Support.

publicationForm

PublishedIns

-	Publisher	PublisherLocation
*	HL7 International	Ann Arbor (MI)

citedMedium: Internet without issue

articleDate: 2025-03-28

copyright:

© 2024+ HL7 International / Clinical Decision Support.

webLocation

classifier: Full-Text, Version Specific, Webpage

​url: http://hl7.org/fhir/uv/ebm/2025May/

Classifications

-	Type	Classifier
*	Knowledge Artifact Type	Database Entry

contributorship

Entries

-	Contributor	Role
*	Organization HL7 International	Publisher

Summaries

-	Type	Source	Value
*	Contributorship statement	Copied from article	This Implementation Guide was made possible by the thoughtful contributions of many, including but not limited to the following people and organizations: Brian S. Alper, MD, MSPH, FAAFP, FAMIA, FGIN, Computable Publishing LLC (US) - Editor Khalid Shahin, Computable Publishing LLC (US) - Committer Joanne Dehnbostel, MS, MPH, Computable Publishing LLC (US) Health Evidence Knowledge Accelerator (HEvKA) Scientific Knowledge Accelerator Foundation Clinical Decision Support (CDS) Work Group Clinical Quality Information (CQI) Work Group Biomedical Research and Regulation (BRR) Work Group Structured Documents (SD) Work Group Guidelines International Network Technology Working Group (GINTech) Muhammad Afzal, PhD, FHEA, Birmingham City University (England) Rachel Couban, McMaster University (Canada) Christopher M. Enright, Computable Publishing LLC (US) Sophie Klopfenstein, MD, Berlin Institute of Health at Charité – Universitätsmedizin Berlin (Germany) Bhagvan Kommadi, MS, Capri Global Capital Ltd. (India) Ilkka Kunnamo, MD, PhD, Duodecim Publishing Company (Finland) Harold Lehmann, MD, PhD, Johns Hopkins University (US) Gregor Lichtner, PhD, Universitätsmedizin Greifswald (Germany) Matthias Löbe, IMISE, Universität Leipzig (Germany) Bryn Rhodes, Smile Digital Health (US) Karen A. Robinson, PhD, Johns Hopkins University (US) Mario Tristan, IHCAI Institute (Costa Rica) Janice Tufte, Hassanah Consulting (US) Yunwei Wang, MITRE (US) Kenneth J. Wilkins, PhD, National Institutes of Health, National Institute of Diabetes & Digestive & Kidney Diseases (NIH/NIDDK) (US)

Generated Narrative: Organization #contributor0

name: HL7 International